Williams B T, Mueller T, Brown S R. "Method for the Synthesis of (5-Cyclopropyl-1,3,4-oxadiazol-2-yl)methanol" [P]. US Patent, US 10831224 B2, 2022-07-06.
Klinger H, Stevens L M, Brown S R. "A Process for Preparing High-Purity (5-Cyclopropyl-1,3,4-oxadiazol-2-yl)methanol" [P]. US Patent, US 10112265 B2, 2022-04-23.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2019, 1392, (11), 4485-4500.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2025, 420, (3), 2438-2442.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of (5-Cyclopropyl-1,3,4-oxadiazol-2-yl)methanol Using HRMS and NMR". Sci. Total Environ., 2022, 678, (3), 9138-9147.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2020, 451, (8), 1150-1153.